Medicare carrier Palmetto GBA is proposing new processes that govern how it will handle code stack claims for molecular diagnostic tests (MDT) and laboratory-developed tests (LDT) in the J1 region, to become effective on February 27, 2012. This marks the first known effort by a payer to address specific problems caused when laboratories submit code stacked claims for genetic tests and molecular diagnostics assays.
These important developments will be covered in a special audio conference to be conducted on Tuesday, December 20, 2012, by The Dark Report. Featured speakers from Palmetto GBA include Elaine Jeter, MD, medical director; and Mike Barlow, vice president.
To view topics of discussion or to register for the audio conference, click here.
Source: The Dark Report
